206 related articles for article (PubMed ID: 37833281)
1. Rewiring of the promoter-enhancer interactome and regulatory landscape in glioblastoma orchestrates gene expression underlying neurogliomal synaptic communication.
Chakraborty C; Nissen I; Vincent CA; Hägglund AC; Hörnblad A; Remeseiro S
Nat Commun; 2023 Oct; 14(1):6446. PubMed ID: 37833281
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer.
Okabe A; Kaneda A
Cancer Sci; 2021 Jun; 112(6):2081-2088. PubMed ID: 33728716
[TBL] [Abstract][Full Text] [Related]
3. Early adaptive chromatin remodeling events precede pathologic phenotypes and are reinforced in the failing heart.
Chapski DJ; Cabaj M; Morselli M; Mason RJ; Soehalim E; Ren S; Pellegrini M; Wang Y; Vondriska TM; Rosa-Garrido M
J Mol Cell Cardiol; 2021 Nov; 160():73-86. PubMed ID: 34273410
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic enhancers: common features, regulation, and participation in diseases.
Erokhin M; Vassetzky Y; Georgiev P; Chetverina D
Cell Mol Life Sci; 2015 Jun; 72(12):2361-75. PubMed ID: 25715743
[TBL] [Abstract][Full Text] [Related]
5. Lineage specific transcription factors and epigenetic regulators mediate TGFβ-dependent enhancer activation.
Fueyo R; Iacobucci S; Pappa S; Estarás C; Lois S; Vicioso-Mantis M; Navarro C; Cruz-Molina S; Reyes JC; Rada-Iglesias Á; de la Cruz X; Martínez-Balbás MA
Nucleic Acids Res; 2018 Apr; 46(7):3351-3365. PubMed ID: 29438503
[TBL] [Abstract][Full Text] [Related]
6. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
7. Bridging between Mouse and Human Enhancer-Promoter Long-Range Interactions in Neural Stem Cells, to Understand Enhancer Function in Neurodevelopmental Disease.
D'Aurizio R; Catona O; Pitasi M; Li YE; Ren B; Nicolis SK
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887306
[TBL] [Abstract][Full Text] [Related]
8. Global analysis of histone modifications and long-range chromatin interactions revealed the differential cistrome changes and novel transcriptional players in human dilated cardiomyopathy.
Liu CF; Abnousi A; Bazeley P; Ni Y; Morley M; Moravec CS; Hu M; Tang WHW
J Mol Cell Cardiol; 2020 Aug; 145():30-42. PubMed ID: 32533974
[TBL] [Abstract][Full Text] [Related]
9. Connectome and regulatory hubs of CAGE highly active enhancers.
Briend M; Rufiange A; Moncla LM; Mathieu S; Bossé Y; Mathieu P
Sci Rep; 2023 Apr; 13(1):5594. PubMed ID: 37019979
[TBL] [Abstract][Full Text] [Related]
10. Characterization of genome-wide enhancer-promoter interactions reveals co-expression of interacting genes and modes of higher order chromatin organization.
Chepelev I; Wei G; Wangsa D; Tang Q; Zhao K
Cell Res; 2012 Mar; 22(3):490-503. PubMed ID: 22270183
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus.
Wu Y; Jia Z; Ge X; Wu Q
Sci China Life Sci; 2020 Jun; 63(6):835-844. PubMed ID: 32249388
[TBL] [Abstract][Full Text] [Related]
12. Mapping chromatin accessibility and active regulatory elements reveals pathological mechanisms in human gliomas.
Stępniak K; Machnicka MA; Mieczkowski J; Macioszek A; Wojtaś B; Gielniewski B; Poleszak K; Perycz M; Król SK; Guzik R; Dąbrowski MJ; Dramiński M; Jardanowska M; Grabowicz I; Dziedzic A; Kranas H; Sienkiewicz K; Diamanti K; Kotulska K; Grajkowska W; Roszkowski M; Czernicki T; Marchel A; Komorowski J; Kaminska B; Wilczyński B
Nat Commun; 2021 Jun; 12(1):3621. PubMed ID: 34131149
[TBL] [Abstract][Full Text] [Related]
13. Regulatory Domains and Their Mechanisms.
Benabdallah NS; Bickmore WA
Cold Spring Harb Symp Quant Biol; 2015; 80():45-51. PubMed ID: 26590168
[TBL] [Abstract][Full Text] [Related]
14. Chromatin Interactions and Regulatory Elements in Cancer: From Bench to Bedside.
See YX; Wang BZ; Fullwood MJ
Trends Genet; 2019 Feb; 35(2):145-158. PubMed ID: 30577989
[TBL] [Abstract][Full Text] [Related]
15. Cell-specific alterations in Pitx1 regulatory landscape activation caused by the loss of a single enhancer.
Rouco R; Bompadre O; Rauseo A; Fazio O; Peraldi R; Thorel F; Andrey G
Nat Commun; 2021 Dec; 12(1):7235. PubMed ID: 34903763
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy.
Papait R; Cattaneo P; Kunderfranco P; Greco C; Carullo P; Guffanti A; Viganò V; Stirparo GG; Latronico MV; Hasenfuss G; Chen J; Condorelli G
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20164-9. PubMed ID: 24284169
[TBL] [Abstract][Full Text] [Related]
17. Hepatic-specific accessibility of Igf1 gene enhancers is independent of growth hormone signaling.
Santhanam M; Chia DJ
Mol Endocrinol; 2013 Dec; 27(12):2080-92. PubMed ID: 24109593
[TBL] [Abstract][Full Text] [Related]
18. Multimodal profiling of the transcriptional regulatory landscape of the developing mouse cortex identifies Neurog2 as a key epigenome remodeler.
Noack F; Vangelisti S; Raffl G; Carido M; Diwakar J; Chong F; Bonev B
Nat Neurosci; 2022 Feb; 25(2):154-167. PubMed ID: 35132236
[TBL] [Abstract][Full Text] [Related]
19. Chromatin connectivity maps reveal dynamic promoter-enhancer long-range associations.
Zhang Y; Wong CH; Birnbaum RY; Li G; Favaro R; Ngan CY; Lim J; Tai E; Poh HM; Wong E; Mulawadi FH; Sung WK; Nicolis S; Ahituv N; Ruan Y; Wei CL
Nature; 2013 Dec; 504(7479):306-310. PubMed ID: 24213634
[TBL] [Abstract][Full Text] [Related]
20.
Yao X; Tan J; Lim KJ; Koh J; Ooi WF; Li Z; Huang D; Xing M; Chan YS; Qu JZ; Tay ST; Wijaya G; Lam YN; Hong JH; Lee-Lim AP; Guan P; Ng MSW; He CZ; Lin JS; Nandi T; Qamra A; Xu C; Myint SS; Davies JOJ; Goh JY; Loh G; Tan BC; Rozen SG; Yu Q; Tan IBH; Cheng CWS; Li S; Chang KTE; Tan PH; Silver DL; Lezhava A; Steger G; Hughes JR; Teh BT; Tan P
Cancer Discov; 2017 Nov; 7(11):1284-1305. PubMed ID: 28893800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
